GSM Foils Kicks Off FY27 Strong with ₹96.9 Cr Revenue, ₹7.6 Cr PAT in Q1
GSM Foils Limited (NSE: GSMFOILS), a leading manufacturer of pharmaceutical packaging foils, has reported a strong start to FY27, delivering healthy revenue and profitability during the quarter ended June 30, 2026. According to the company’s latest investor presentation, GSM Foils continued to benefit from rising demand for high-quality pharmaceutical packaging products, supported by expanding manufacturing capabilities and a growing customer base.
The company reported revenue of ₹96.9 crore and profit after tax (PAT) of ₹7.6 crore during the first quarter, reflecting its continued focus on operational efficiency and value-added product offerings.
GSM Foils Q1 FY27 Financial Highlights
| Particulars | Q1 FY27 |
|---|---|
| Total Revenue | ₹96.9 crore |
| Profit After Tax (PAT) | ₹7.6 crore |
The strong quarterly performance highlights the company’s growing presence in India’s pharmaceutical packaging industry, where demand for high-quality blister and aluminium foils continues to increase alongside pharmaceutical production.
Strengthening Position in Pharmaceutical Packaging
Founded in 2019, GSM Foils has rapidly established itself as a trusted supplier of pharmaceutical packaging materials. The company manufactures premium-quality aluminium and blister foils designed to meet stringent pharmaceutical industry standards.
Its products are recognized for:
- Excellent sealing performance.
- High tensile strength.
- Superior abrasion resistance.
- Consistent product quality.
- Compliance with pharmaceutical packaging requirements.
The company also holds ISO 9001:2015 certification, reflecting its commitment to quality management and manufacturing excellence.
Operational Highlights
GSM Foils continues to strengthen its manufacturing capabilities and market reach.
Key Business Metrics
- Production Capacity: More than 17,000 MT per annum.
- Customer Base: Over 110 clients.
- Geographical Presence: Operations across 14+ Indian states.
- Manufacturing Facility: Approximately 31,500 sq. ft. with 21+ advanced manufacturing units.
- Core Product Portfolio: Pharmaceutical foils in the 20–40 micron range.
These operational strengths have enabled the company to serve leading pharmaceutical manufacturers while maintaining consistent product quality and delivery standards.
Capacity Expansion to Support Future Growth
To meet increasing demand, GSM Foils continues to invest in manufacturing infrastructure and operational efficiency.
Recent initiatives include:
- Installation of advanced machinery and production tools.
- Enhancement of heating capacity.
- Improvement in production speed.
- Greater manufacturing efficiency.
- Continued focus on premium-quality output.
These investments are expected to support higher production volumes while improving operational productivity in the coming quarters.
Industry Outlook
India’s pharmaceutical sector remains one of the fastest-growing healthcare markets globally, driving sustained demand for specialized packaging materials.
As pharmaceutical companies expand production and regulatory standards become more stringent, demand for high-quality aluminium and blister foils is expected to remain strong.
With its expanding production capacity, established customer relationships, and continued investment in technology, GSM Foils appears well-positioned to benefit from these long-term industry trends.